Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-22.29%
operating margin TTM
-121.96%
revenue TTM
303.73 Million
revenue per share TTM
4.23$
valuation ratios | |
|---|---|
| pe ratio | -6.45 |
| peg ratio | -0.06 |
| price to book ratio | 0.07 |
| price to sales ratio | 1.04 |
| enterprise value multiple | -238.20 |
| price fair value | 0.07 |
profitability ratios | |
|---|---|
| gross profit margin | 59.51% |
| operating profit margin | -121.96% |
| pretax profit margin | -34.14% |
| net profit margin | -22.29% |
| return on assets | -0.73% |
| return on equity | -1.13% |
| return on capital employed | -4.37% |
liquidity ratios | |
|---|---|
| current ratio | 10.31 |
| quick ratio | 10.18 |
| cash ratio | 1.11 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 281.26 |
| operating cycle | 648.26 |
| days of payables outstanding | 34.77 |
| cash conversion cycle | 613.49 |
| receivables turnover | 0.99 |
| payables turnover | 10.50 |
| inventory turnover | 1.30 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.02 |
| total debt to capitalization | 0.03 |
| interest coverage | -241.91 |
| cash flow to debt ratio | 0.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.42 |
| cash per share | 112.67 |
| operating cash flow per share | 1.04 |
| free cash flow operating cash flow ratio | -0.40 |
| cash flow coverage ratios | 0.35 |
| short term coverage ratios | 1.37 |
| capital expenditure coverage ratio | 0.71 |
Frequently Asked Questions
When was the last time Sinovac Biotech Ltd. (NASDAQ:SVA) reported earnings?
Sinovac Biotech Ltd. (SVA) published its most recent earnings results on 31-12-2023.
What is Sinovac Biotech Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sinovac Biotech Ltd. (NASDAQ:SVA)'s trailing twelve months ROE is -1.13%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sinovac Biotech Ltd. (SVA) currently has a ROA of -0.73%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SVA's net profit margin stand at?
SVA reported a profit margin of -22.29% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SVA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.31 in the most recent quarter. The quick ratio stood at 10.18, with a Debt/Eq ratio of 0.03.